Guidelines for point-of-care testing in Spain:
This article was originally published in Clinica
Executive Summary
Ahead of the expected rapid growth in point-of-care testing in Spain, guidelines are to be issued regarding good working practice and quality standards. Sediglac, the clinical laboratory sector's umbrella organisation, is drafting recommendations which, it hopes, will influence healthcare administration. They are due for release in June. Dr Carles Pascual, president of Sediglac, has highlighted the extent to which the organisation is promoting a closer relationship between laboratories and healthcare providers in a rapidly evolving market.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.